Search results for "parathyroid"

showing 10 items of 164 documents

Surgeon volume and hospital volume in endocrine neck surgery: how many procedures are needed for reaching a safety level and acceptable costs? A syst…

2018

The relationship between quality of care and provider's experience is well known in all fields of surgery. Even in thyroidectomies and parathyroidectomies, the emphasis on positive volume-outcome relationships is believed. It led us to an evaluation of volume activity's impact in terms of quality of care. A systematic narrative review was performed. According to the PRISMA criteria, we selected 87 paper and, after the study selection was performed, 22 studies were finally included in this review. All articles included were unanimous in attributing to activity volume of surgeons as well as centers a substantial importance. Some differences in outcomes between these investigated categories ha…

Reoperationmedicine.medical_specialtyHospitals Low-VolumeCost-Benefit Analysismedicine.medical_treatmentOperative TimeMEDLINEReview030230 surgery03 medical and health sciencesPostoperative Complications0302 clinical medicineHospital volumemedicineHumansHospital CostsQuality of careendocrine surgerySurgeon volumeParathyroidectomySurgeonsbusiness.industryLength of StaySingle surgeonSurgeryEndocrine surgery030220 oncology & carcinogenesisThyroidectomyNarrative reviewbusinessHospital stayHospitals High-VolumeProcedures and Techniques Utilization
researchProduct

PARATHYROID HORMONE INCREASES AFTER ORAL PEPTONES ADMINISTRATION IN OBESE SUBJECTS TREATED WITH ROUX-EN-Y GASTRIC BYPASS SURGERY: ROLE OF PHOSPHATE O…

2008

Settore MED/09 - Medicina InternaPARATHYROID HORMONE GASTRIC BYPASS PHOSPHATE
researchProduct

Analisi dei fattori di rischio dell'ipoparatiroidismo transitorio e definitivo nei pazienti sottoposti a tiroidectomia

2017

Obiettivi. Con questa revisione della letteratura ci proponiamo di valutare quali sono i fattori che possono essere valutati nei pazienti da sottoporre a tiroidectomia ai fini di una migliore gestione preoperatoria e post-operatoria dell’ipoparatiroidismo transitorio e definitivo. Discussione. L’ipoparatiroidismo transitorio è una complicanza potenzialmente grave che include una vasta gamma di segni e sintomi che permane solo per poche settimane dopo l’intervento chirurgico. L’ipoparatiroidismo definitivo si verifica quando è necessario un trattamento medico per un periodo maggiore di 12 mesi. I fattori di rischio che ne possono influenzare l’insorgenza in seguito ad interventi di tiroidect…

Settore MED/18 - Chirurgia GeneraleHipoparathyroidismcalcio fattori di rischio ipoparatiroidismo paratormone tiroidectomiaThyroidectomyCalciumRisk factorcalcium; hipoparathyroidism; parathyroid hormone; risk factors; thyroidectomy; Medicine (all)Parathyroid hormone
researchProduct

Surgical complications in prophylactic central neck dissection: Preliminary findings from a retrospective cohort study

2014

Aim. Papillary thyroid carcinoma (PTC) is the most frequent thyroid malignancy with an overall ten-year survival more than 90%. Total thyroidectomy (TT) is considered the gold standard for PTC, but not all the endocrine surgeons agree on central neck dissection except in case of known metastases. Methods. We enrolled 158 patients, that underwent, between January 1990 and September 2012 total thyroidectomy±prophylactic CND for PTC. 59 Patients (group A) had a preoperative diagnosis of PTC; 99 (group B) had a diagnosis of benign disease. We focused on possible complications. Results. In group A we had 4 patients who blamed a definitive RLN palsy, only 1 patient in group B, with an OR=7.12. De…

Settore MED/18 - Chirurgia GeneraleHypoparathyroidismVocal cord paralysisPapillaryThyroidectomyThyroid cancer
researchProduct

Il trattamento medico e chirurgico nei pazienti affetti da iperparatiroidismo secondario e terziario. Revisione della letteratura

2017

Introduzione: L’iperparatiroidismo è un’alterazione fisiopatologica della secrezione di paratormone dovuta o da un rilascio autonomo e anomalo (iperparatiroidismo primario o terziario) da parte delle paratiroidi o da un’alterazione dell’omeostasi del calcio che stimola l’eccessiva produzione di paratormone (iperparatiroidismo secondario). Obiettivi: Il trattamento clinico dell’iperparatiroidismo secondario o terziario non è univoco. Sorge pertanto la necessità di una revisione delle attuali metodiche diagnostico-terapeutiche. Discussione: Nell’iperparatiroidismo secondario (2HPT) si ha una progressiva iperplasia delle paratiroidi e un incremento della produzione di paratormone. Tra le cause…

Settore MED/18 - Chirurgia GeneraleIperparatiroidismo secondario Iperparatiroidismo terziario Paratormone Trattamento chirurgico Trattamento medicoMedical treatment Parathormone Secondary hyperparathyroidism Surgical treatment Thertiary hyperparathyroidismSettore MED/13 - Endocrinologia
researchProduct

Reoperation for persistent or recurrent secondary hyperparathyroidism

2017

Background: Secondary hyperparathyroidism is a common acquired disorder seen in chronic renal failure. Its pathophysiology is mainly due to hyperphosphatemia and vitamin D deficiency and resistance. When medical treatment fails, subtotal and total parathyroidectomy with autotransplantation are the standard procedures, although both are associated with high recurrence rates.Methods and Results: 4 patients experienced persistence and 9 relapse. The first 4 were subjected to reoperation after 6 months for the persistence of symptoms due to the finding of a supernumerary adenomatous gland while the remaining patients at the reoperation showed in 5 cases 2 more glands in over thymic position, an…

Settore MED/18 - Chirurgia Generaleintraoperative parathyroid hormone measurement; persistent hyperparathyroidism; recurrent hyperparathyroidism; subtotal parathyroidectomyrecurrent hyperparathyroidismpersistent hyperparathyroidismsubtotal parathyroidectomyIntraoperative parathyroid hormone measurementSettore MED/13 - Endocrinologia
researchProduct

Improvement of quality of life during treatment with anabolic therapy: results of multicenter study

2012

Settore MED/34 - Medicina Fisica E Riabilitativaanabolic therapy multicenter study parathyroid hormone
researchProduct

The Italian observational study on severe osteoporosis (ISSO): 24-month results on incidence of fractures and adherence to treatment

2016

Objective To estimate the proportion of patients with very severe osteoporosis (those covered by the reimbursement criteria of the Italian National Health Service) experiencing new vertebral and non-vertebral fragility fractures in the first 24 months of a new anti-osteoporosis treatment. Methods Prospective observational study in men and post-menopausal women (aged > 21 years) initiating anti-osteoporosis treatment for very severe osteoporosis. Eligibility was based on teriparatide (TPD) reimbursement criteria in Italy: Incident of vertebral or hip fracture during anti-resorptive treatment (minimum 1 year), or at least three prevalent severe vertebral fractures, or two prevalent severe ver…

Spinal fractureFractureRheumatologyObservational studyOsteoporosis therapyTeriparatideImmunologyOsteoporosiImmunology and AllergyParathyroid hormoneSpine
researchProduct

Invasive Diagnostics and Therapy

2022

The book is an update on contentious or unsettled issues concerning invasive diagnostic and therapeutic challenges in cancer and related disorders, focusing on the surgical approach. Topics include recommendations for the best practice in using the surgery safety checklist, surgical strategies in a variety of thoracic cancers, renal cell carcinoma, tumors of parathyroid glands, mesothelioma, and bariatric surgeries. The focus is on the diagnostic and therapeutic challenges of aggressive cancerous entities, choosing the most beneficial modes for optimal outcomes and patient survival. Chapters also address radioimaging and therapy outcomes in different intracranial lesions leading to severe n…

Surgery safety checklistThoracic surgeryquality of lifeBrain lesionsHyperparathyroidismInvasive proceduresClinical practiceRenal cell carcinomaCancer
researchProduct

TREATMENT WITH DAILY SUBCUTANEOUS TERIPARATIDE (1-34) COMPARED WITH DAILY SUBCUTANEOUS PARATHYROID HORMONE (1-84) IN WOMEN WITH SEVERE POSTMENOPAUSAL…

2008

TERIPARATIDE PARATHYROID HORMONE OSTEOPOROSIS BONE TURNOVER BMDSettore MED/09 - Medicina Interna
researchProduct